CSIMarket
 


Champions Oncology Inc   (CSBR)
Other Ticker:  
 
 

CSBR's EPS from Cont. Operations Growth by Quarter and Year

Champions Oncology Inc 's EPS from Cont. Operations results by quarter and year




CSBR EPS from Cont. Operations (in $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter April - -0.19 -0.03 -0.03
III Quarter January -0.19 -0.18 0.06 0.06
II Quarter October -0.15 0.00 0.02 0.00
I Quarter July -0.19 -0.02 -0.01 0.01
FY   -0.53 -0.39 0.04 0.04



CSBR EPS from Cont. Operations third quarter 2024 Y/Y Growth Comment
Champions Oncology Inc in the third quarter 2024 recorded EPS loss from Cont. Operations of $ -0.19 .

According to the results reported in the third quarter 2024, Champions Oncology Inc achieved the best EPS from Cont. Operations growth in Biotechnology & Pharmaceuticals industry. While Champions Oncology Inc ' s EPS from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2024.




CSBR EPS from Cont. Operations ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter April - - - -
III Quarter January - - 0 % 100 %
II Quarter October - - - -
I Quarter July - - - -
FY   - - 0 % -

Financial Statements
Champions Oncology Inc 's third quarter 2024 EPS from Cont. Operations $ -0.19 CSBR's Income Statement
Champions Oncology Inc 's third quarter 2023 EPS from Cont. Operations $ -0.18 Quarterly CSBR's Income Statement
New: More CSBR's historic EPS from Cont. Operations Growth >>


CSBR EPS from Cont. Operations (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter April - - - -
III Quarter January - - 200 % -
II Quarter October - - - -
I Quarter July - - - -
FY (Year on Year)   - - 0 % -




EPS from Cont. Operations third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS from Cont. Operations third quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS from Cont. Operations by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Champions Oncology Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CSBR's III. Quarter Q/Q EPS from Cont. Operations Comment
Current results of -0.19 by Champions Oncology Inc look even more unfavourable compare to the -0.15 EPS loss from Cont. Operations in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Champions Oncology Inc achieved highest sequential EPS from Cont. Operations growth. While Champions Oncology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CSBR's III. Quarter Q/Q EPS from Cont. Operations Comment
Current EPS loss from Cont. Operations of -0.19 by Champions Oncology Inc appear even worse if you take a look at -0.15 EPS loss from Cont. Operations in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Champions Oncology Inc achieved highest sequential EPS from Cont. Operations growth. While Champions Oncology Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is .


Champions Oncology Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Jan 31 2024)
12 Months Ending
(Oct 31 2023)
12 Months Ending
(Jul 31 2023)
12 Months Ending
(Apr 30 2023)
12 Months Ending
(Jan 31 2023)
Cumulative EPS from Cont. Operations 12 Months Ending $ -0.72 $ -0.71 $ 0.00 $ 0.00 $ 0.00
Y / Y EPS from Cont. Operations Growth (TTM) - - - - -
Year on Year EPS from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential EPS from Cont. Operations Change (TTM) - - - - -
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative EPS from Cont. Operations growth Comment
Champions Oncology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jan 31 2024 period.
The business is worsening as the cumulative EPS loss from Cont. Operations is getting bigger from $ -0.71 in TTM ending quarter Oct 31 2023 and $ for the twelve months ending in the quarter Jan 31 2023 Cally Mendes told.

Champions Oncology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS from Cont. Operations growth Comment
Champions Oncology Inc ' has realized cumulative trailing twelve months EPS loss from Cont. Operations of $ -1 in the Jan 31 2024 period.
The business is detiriorating as the cumulative EPS loss from Cont. Operations is inflating from $ -0.71 in the twelve months ending a quarter before and $ from the TTM period ending Jan 31 2023 Cally Mendes wrote.

Champions Oncology Inc achieved highest trailing twelve month year on year EPS from Cont. Operations growth. While overall EPS from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS from Cont. Operations Growth
Biotechnology & Pharmaceuticals Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
CSBR's EPS from Cont. Operations Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for CSBR's Competitors
EPS from Cont. Operations Growth for Champions Oncology Inc 's Suppliers
EPS from Cont. Operations Growth for CSBR's Customers

You may also want to know
CSBR's Annual Growth Rates CSBR's Profitability Ratios CSBR's Asset Turnover Ratio CSBR's Dividend Growth
CSBR's Roe CSBR's Valuation Ratios CSBR's Financial Strength Ratios CSBR's Dividend Payout Ratio
CSBR's Roa CSBR's Inventory Turnover Ratio CSBR's Growth Rates CSBR's Dividend Comparisons



Companies with similar EPS from Cont. Operations no change for the quarter ending Jan 31 2024 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Jan 31 2024
Medtronic Plc7.61%$ 7.609 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com